The molecular pathogenesis of osteosarcoma: a review
- PMID: 21559216
- PMCID: PMC3087974
- DOI: 10.1155/2011/959248
The molecular pathogenesis of osteosarcoma: a review
Abstract
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapid growth and primarily affects adolescents and young adults. The 5-year survival rate for osteosarcoma is 60%-70%, with no significant improvements in prognosis since the advent of multiagent chemotherapy. Diagnosis, staging, and surgical management of osteosarcoma remain focused on our anatomical understanding of the disease. As our knowledge of the molecular pathogenesis of osteosarcoma expands, potential therapeutic targets are being identified. A comprehensive understanding of these mechanisms is essential if we are to improve the prognosis of patients with osteosarcoma through tumour-targeted therapies. This paper will outline the pathogenic mechanisms of osteosarcoma oncogenesis and progression and will discuss some of the more frontline translational studies performed to date in search of novel, safer, and more targeted drugs for disease management.
Figures
Similar articles
-
PTHR1 in osteosarcoma: Specific molecular mechanisms and comprehensive functional perspective.J Cell Mol Med. 2021 Apr;25(7):3175-3181. doi: 10.1111/jcmm.16420. Epub 2021 Mar 6. J Cell Mol Med. 2021. PMID: 33675132 Free PMC article. Review.
-
Osteosarcoma: A comprehensive review of management and treatment strategies.Ann Diagn Pathol. 2020 Dec;49:151654. doi: 10.1016/j.anndiagpath.2020.151654. Epub 2020 Oct 25. Ann Diagn Pathol. 2020. PMID: 33130384 Review.
-
MicroRNAs and Potential Targets in Osteosarcoma: Review.Front Pediatr. 2015 Aug 24;3:69. doi: 10.3389/fped.2015.00069. eCollection 2015. Front Pediatr. 2015. PMID: 26380245 Free PMC article. Review.
-
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success.J Clin Oncol. 2015 Sep 20;33(27):3029-35. doi: 10.1200/JCO.2014.59.4895. Epub 2015 Aug 24. J Clin Oncol. 2015. PMID: 26304877 Free PMC article. Review.
-
Biology of osteogenic sarcoma.Cancer J. 2005 Jul-Aug;11(4):294-305. doi: 10.1097/00130404-200507000-00005. Cancer J. 2005. PMID: 16197719 Review.
Cited by
-
HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival.Sci Rep. 2016 Aug 17;6:31154. doi: 10.1038/srep31154. Sci Rep. 2016. PMID: 27531281 Free PMC article.
-
Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge and Limitations.Biomolecules. 2024 Jan 24;14(2):145. doi: 10.3390/biom14020145. Biomolecules. 2024. PMID: 38397382 Free PMC article. Review.
-
ALT Positivity in Human Cancers: Prevalence and Clinical Insights.Cancers (Basel). 2021 May 14;13(10):2384. doi: 10.3390/cancers13102384. Cancers (Basel). 2021. PMID: 34069193 Free PMC article. Review.
-
miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b.Cell Cycle. 2019 Dec;18(23):3325-3336. doi: 10.1080/15384101.2019.1676087. Epub 2019 Oct 10. Cell Cycle. 2019. PMID: 31601147 Free PMC article.
-
Osteosarcoma cell proliferation and migration are partly regulated by redox-activated NHE-1.J Clin Transl Res. 2015 Dec 12;1(3):168-179. eCollection 2015 Dec 30. J Clin Transl Res. 2015. PMID: 30873452 Free PMC article.
References
-
- Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. Journal of Clinical Oncology. 2002;20(3):776–790. - PubMed
-
- Vigorita VJ. Orthopaedic Pathology. Philadelphia, Pa, USA: Lippincott, Williams & Wilkins; 2008.
-
- Canale ST, Beaty JH. Campbell’s Operative Orthopaedics. Mosby Elsvier; 2008.
-
- Cotterill SJ, Wright CM, Pearce MS, Craft AW. Stature of young people with malignant bone tumors. Pediatric Blood and Cancer. 2004;42(1):59–63. - PubMed
-
- Gelberg KH, Fitzgerald EF, Hwang SA, Dubrow R. Growth and development and other risk factors for osteosarcoma in children and young adults. International Journal of Epidemiology. 1997;26(2):272–278. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials